Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
Author:
Funder
Pfizer Inc
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference18 articles.
1. Novel oncologic drugs: what they do and how they affect images;Figueiras;Radiographics,2011
2. Targeted therapies in renal cell cancer: recent developments in imaging;van der Veldt;Target Oncol,2010
3. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J Natl Cancer Inst,2000
4. Sunitinib: from rational design to clinical efficacy;Chow;J Clin Oncol,2007
5. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2006
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Terminal Unfolded Protein Responses-related genes predict prognosis and associate with proliferation and apoptosis in clear cell renal cell carcinoma;2024-01-19
2. Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib;Biomedicines;2024-01-10
3. Identification of prognostic coagulation-related signatures in clear cell renal cell carcinoma through integrated multi-omics analysis and machine learning;Computers in Biology and Medicine;2024-01
4. Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC;International Journal of Molecular Sciences;2023-12-22
5. Effects of RNA methylation on Tumor angiogenesis and cancer progression;Molecular Cancer;2023-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3